U.S. flag

An official website of the United States government

NM_001039876.3(SYNE4):c.940C>T (p.His314Tyr) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Sep 2, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000615818.4

Allele description [Variation Report for NM_001039876.3(SYNE4):c.940C>T (p.His314Tyr)]

NM_001039876.3(SYNE4):c.940C>T (p.His314Tyr)

Gene:
SYNE4:spectrin repeat containing nuclear envelope family member 4 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.12
Genomic location:
Preferred name:
NM_001039876.3(SYNE4):c.940C>T (p.His314Tyr)
HGVS:
  • NC_000019.10:g.36005365G>A
  • NG_042831.1:g.8429C>T
  • NM_001039876.3:c.940C>TMANE SELECT
  • NM_001297735.3:c.601C>T
  • NP_001034965.1:p.His314Tyr
  • NP_001284664.1:p.His201Tyr
  • LRG_1385t1:c.940C>T
  • LRG_1385:g.8429C>T
  • LRG_1385p1:p.His314Tyr
  • NC_000019.9:g.36496267G>A
  • NM_001039876.1:c.940C>T
Protein change:
H201Y
Links:
dbSNP: rs886101498
NCBI 1000 Genomes Browser:
rs886101498
Molecular consequence:
  • NM_001039876.3:c.940C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001297735.3:c.601C>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000731838Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Uncertain significance
(Sep 2, 2017)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided11not providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000731838.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

Variant classified as Uncertain Significance - Favor Benign. The p.His314Tyr var iant in SYNE4 has not been previously reported in individuals with hearing loss, but has been identified in 1/14980 European chromosomes by the Genome Aggregati on Database (gnomAD, http://gnomad.broadinstitute.org). Although this variant ha s been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Histidine (His) at position 314 is not conserved across s pecies and 2 mammals have a Tyrosine (Tyr) at this position. Additional computat ional prediction tools suggest that the p.His314Tyr variant may not impact the p rotein, though this information is not predictive enough to rule out pathogenici ty. In summary, while the clinical significance of the p.His314Tyr variant is un certain, these data suggest that it is more likely to be benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided1not provided1not provided

Last Updated: Dec 24, 2022